DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidCLTIperipheral arterial diseaserest paingangrenerevascularisation

Chronic limb-threatening ischaemia

Essential points for quick revision.

!
Escalate

CLTI needs urgent vascular referral. Wet gangrene, spreading infection/sepsis, rapidly worsening pain or a diabetic foot with ulcer plus limb ischaemia is a limb- and sometimes life-threatening emergency requiring same-day acute assessment.

Synopsis

Recognise ischaemic rest pain and tissue loss, protect the foot and secure urgent multidisciplinary revascularisation assessment before preventable amputation.

  • CLTI is chronic PAD with ischaemic rest pain, non-healing ulceration or gangrene; it replaces the older term critical limb ischaemia.
  • Forefoot pain that is worse when supine and relieved by hanging the foot down is classic ischaemic rest pain.
  • Tissue loss is often distal and punched out, with a cool hairless foot, delayed refill and reduced pulses; neuropathy may blunt pain.

Key red flags

Ischaemic rest pain

Persistent forefoot/toe pain, often nocturnal and worse with elevation, relieved transiently by dependency; requires urgent vascular assessment.

Investigation priorities

01
ABPI with Doppler waveformsFirst step

Objectify PAD and describe arterial signals.

Management branches

urgentNew CLTI

Rest pain, non-healing arterial ulcer or gangrene without acute motor/sensory loss.

  1. First: urgent vascular MDT referral; document wound, pulses/Doppler, sensation, infection and analgesic needs.
  2. Next: protect the foot, avoid trauma and inappropriate compression, and obtain ABPI plus toe/waveform testing where needed.

Key medicines

Clopidogrel75 mg orally once daily.
Atorvastatin80 mg orally once daily for secondary prevention; use a lower dose if interactions, adverse-effect risk or patient preference require it.
Open full textbook Answer 2 questionsCardiology check
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom